Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDO INTERNATIONAL PLC ENDPQ

Healthcare Drug Manufacturers - Specialty & Generic
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Recent & Breaking News (GREY:ENDPQ)

Endo to Present at Morgan Stanley Global Healthcare Conference 2014

PR Newswire September 8, 2014

Endo announces launch of Authorized Generic of FORTESTA® Gel

PR Newswire September 8, 2014

Endo completes acquisition of DAVA Pharmaceuticals

PR Newswire August 6, 2014

Paladin Labs Announces the Canadian Launch of Travelan®

Canada NewsWire August 5, 2014

Endo Reports Second Quarter Financial Results

PR Newswire July 31, 2014

Endo appoints Shane M. Cooke to Board of Directors

PR Newswire July 30, 2014

Endo completes acquisition of Grupo Farmaceutico Somar®

PR Newswire July 24, 2014

Paladin Labs Announces the Canadian Launch of Veregen®

Canada NewsWire July 16, 2014

Endo to Announce Second Quarter 2014 Financial Results on July 31, 2014

PR Newswire July 15, 2014

Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain

PR Newswire July 7, 2014

Endo International plc Announces Pricing of Private Offering Of Senior Notes

PR Newswire June 25, 2014

Endo International plc Announces Proposed Private Offering Of Senior Notes

PR Newswire June 25, 2014

Endo to Acquire DAVA Pharmaceuticals

PR Newswire June 24, 2014

Trendlines Acquires Intellectual Property from Collaboration with Endo

Business Wire June 18, 2014

Trendlines Acquires Intellectual Property from Collaboration with Endo

PR Newswire June 18, 2014

American Medical Systems Enrolls First Patient in Embrace, a 522 Post Market Surveillance Study for the Elevate(TM) Anterior and Apical Prolapse System

PR Newswire June 9, 2014

Endo Completes Sale of Early Stage Drug Discovery Portfolio

PR Newswire June 2, 2014

Endo Completes Acquisition of Rights to Sumavel® DosePro®

PR Newswire May 19, 2014

Endo Announces Appearances at Upcoming Conferences

PR Newswire May 9, 2014

Endo Health Solutions Inc. Final Results and Settlement of Exchange Offers and Consent Solicitations Relating to its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022

PR Newswire May 6, 2014